Log in

Relevant bibliographies by topics / Inflammation Mediators / Journal articles

To see the other types of publications on this topic, follow the link: Inflammation Mediators.

Journal articles on the topic 'Inflammation Mediators'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Inflammation Mediators.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Finsnes, Finn, Torstein Lyberg, Geir Christensen, and Ole H. Skjønsberg. "Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation." American Journal of Physiology-Lung Cellular and Molecular Physiology 280, no. 4 (2001): L659—L665. http://dx.doi.org/10.1152/ajplung.2001.280.4.l659.

Full text

Abstract:

Endothelin (ET)-1 has been launched as an important mediator in bronchial asthma, which is an eosinophilic airway inflammation. However, the interplay between ET-1 and other proinflammatory mediators during the development of airway inflammation has not been elucidated. We wanted to study 1) whether the production of ET-1 precedes the production of other proinflammatory mediators and 2) whether ET-1 stimulates the production of these mediators within the airways. These hypotheses were studied during the development of an eosinophilic airway inflammation in rats. The increase in ET-1 mRNA level

APA, Harvard, Vancouver, ISO, and other styles

2

GREAVES, M. W. "Inflammation and mediators." British Journal of Dermatology 119, no. 4 (1988): 419–26. http://dx.doi.org/10.1111/j.1365-2133.1988.tb03245.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sacca, R. "Mediators of inflammation." Current Opinion in Immunology 9, no. 6 (1997): 851–57. http://dx.doi.org/10.1016/s0952-7915(97)80189-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Moore, Terry L., and Terry D. Weiss. "Mediators of inflammation." Seminars in Arthritis and Rheumatism 14, no. 4 (1985): 247–62. http://dx.doi.org/10.1016/0049-0172(85)90044-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lazarus, Stephen C. "Inflammation, Inflammatory Mediators, and Mediator Antagonists in Asthma." Journal of Clinical Pharmacology 38, no. 7 (1998): 577–82. http://dx.doi.org/10.1002/j.1552-4604.1998.tb04463.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sudo, Maki, and Koichi Fujimoto. "Diffusive mediator feedbacks control the health-to-disease transition of skin inflammation." PLOS Computational Biology 20, no. 1 (2024): e1011693. http://dx.doi.org/10.1371/journal.pcbi.1011693.

Full text

Abstract:

The spatiotemporal dynamics of inflammation provide vital insights into the understanding of skin inflammation. Skin inflammation primarily depends on the regulatory feedback between pro- and anti-inflammatory mediators. Healthy skin exhibits fading erythema. In contrast, diseased skin exhibits expanding erythema with diverse patterns, which are clinically classified into five types: circular, annular, arcuate, gyrate, and polycyclic. Inflammatory diseases with expanding erythema are speculated to result from the overproduction of pro-inflammatory mediators. However, the mechanism by which fee

APA, Harvard, Vancouver, ISO, and other styles

7

Alderton, Gemma. "Lipid mediators of inflammation." Science 371, no. 6526 (2021): 248.9–250. http://dx.doi.org/10.1126/science.371.6526.248-i.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Robinson, Dwight R. "Lipid Mediators of Inflammation." Rheumatic Disease Clinics of North America 13, no. 2 (1987): 385–405. http://dx.doi.org/10.1016/s0889-857x(21)00854-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Laurent, G. J. "Mediators of Pulmonary Inflammation." Thorax 47, no. 9 (1992): 764. http://dx.doi.org/10.1136/thx.47.9.764-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Lasky, Laurence A. "Combinatorial mediators of inflammation?" Current Biology 3, no. 6 (1993): 366–68. http://dx.doi.org/10.1016/0960-9822(93)90203-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

du Bois, R. M. "Mediators of pulmonary inflammation." Immunology Today 13, no. 10 (1992): 424. http://dx.doi.org/10.1016/0167-5699(92)90100-l.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Reilly, Christopher, Nicole Regna, and Abigail Peairs. "EGCG Inhibits Inflammation Independently of AMPK (87.10)." Journal of Immunology 184, no. 1_Supplement (2010): 87.10. http://dx.doi.org/10.4049/jimmunol.184.supp.87.10.

Full text

Abstract:

Abstract Epigallocatechin-3-gallate (EGCG), a bioactive component of green tea, has been reported to exert anti-inflammatory effects in immune cells. EGCG has been shown to activate the metabolic regulator, AMP-activated protein kinase (AMPK). Mesangial cells from MRL/lpr lupus-like mice are hyper-responsive to immune stimulation and overproduce nitric oxide (NO) and other inflammatory mediators when stimulated. In our current studies, we sought to determine if EGCG would inhibit inflammation in AMPK deficient mesangial cells. Cultured mesangial cells from MRL/lpr mice were treated with siRNA

APA, Harvard, Vancouver, ISO, and other styles

13

Lu, Yan, Song Hong, Katherine Gotlinger, and Charles Serhan. "Lipid Mediator Informatics and Proteomics in Inflammation-Resolution." Scientific World JOURNAL 6 (2006): 589–614. http://dx.doi.org/10.1100/tsw.2006.118.

Full text

Abstract:

Lipid mediator informatics is an emerging area denoted to the identification of bioactive lipid mediators (LMs) and their biosynthetic profiles and pathways. LM informatics and proteomics applied to inflammation, systems tissues research provides a powerful means of uncovering key biomarkers for novel processes in health and disease. By incorporating them with system biology analysis, we review here our initial steps toward elucidating relationships among a range of bimolecular classes and provide an appreciation of their roles and activities in the pathophysiology of disease. LM informatics e

APA, Harvard, Vancouver, ISO, and other styles

14

Ramon, Sesquile, Charles Serhan, and Richard Phipps. "Actions of novel inflammation-resolving lipid mediators on human B cells (84.9)." Journal of Immunology 184, no. 1_Supplement (2010): 84.9. http://dx.doi.org/10.4049/jimmunol.184.supp.84.9.

Full text

Abstract:

Abstract The resolution of inflammation is an active and dynamic process. Newly identified lipid mediators have been recognized as key players during the process of inflammation resolution. These lipid-derived molecules constitute three classes of compounds (lipoxins, resolvins and protectins), all derived from essential fatty acids. New data demonstrates that these lipid mediators regulate aspects of the immune response, including inhibition of neutrophil infiltration, reduction of T cell cytokine production and stimulation of macrophage phagocytic activity. However, their effects on B lympho

APA, Harvard, Vancouver, ISO, and other styles

15

Eerden, Menno M. Van Der. "Mediators Of Inflammation In COPD." Pulmonary Medicine and Respiratory Research 5, no. 2 (2019): 1–10. http://dx.doi.org/10.24966/pmrr-0177/100026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Cooper, P. R., J. L. McLachlan, S. Simon, L. W. Graham, and A. J. Smith. "Mediators of Inflammation and Regeneration." Advances in Dental Research 23, no. 3 (2011): 290–95. http://dx.doi.org/10.1177/0022034511405389.

Full text

Abstract:

Characterization of the molecular response under caries lesions requires a robust and reliable transcript isolation system, and analysis of data indicated that collection of extracted teeth in either liquid nitrogen/RNA-stabilizing solution facilitated this. Subsequent transcriptional analysis indicated higher general activity in carious pulps, while characterization of inflammatory mediators, including cytokines and S100 proteins, highlighted increasing expression levels associated with both microbial front progression and elevated cellular immune response. Analysis of the pleiotropic hormone

APA, Harvard, Vancouver, ISO, and other styles

17

Rankin, James A. "Biological Mediators of Acute Inflammation." AACN Clinical Issues: Advanced Practice in Acute and Critical Care 15, no. 1 (2004): 3–17. http://dx.doi.org/10.1097/00044067-200401000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

LUGER, T. "Mediators of immunity and inflammation." Journal of the European Academy of Dermatology and Venereology 11 (September 1998): S25—S26. http://dx.doi.org/10.1016/s0926-9959(98)94625-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Rand, Royden. "Mediators of immunity and inflammation." Clinical Biochemistry 22, no. 3 (1989): 241–43. http://dx.doi.org/10.1016/s0009-9120(89)80083-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Schlag, G., and H. Redl. "Mediators of Injury and Inflammation." World Journal of Surgery 20, no. 4 (1996): 406–10. http://dx.doi.org/10.1007/s002689900064.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Agrawal, Anshu. "Vision for Mediators of Inflammation." Mediators of Inflammation 2020 (March 4, 2020): 1. http://dx.doi.org/10.1155/2020/9202849.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Lai, Kar Neng, Sydney C. W. Tang, and Joseph C. K. Leung. "Mediators of Inflammation and Fibrosis." Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27, no. 2_suppl (2007): 65–71. http://dx.doi.org/10.1177/089686080702702s12.

Full text

Abstract:

During peritoneal dialysis, peritoneal cells are repeatedly exposed to a non-physiologic hypertonic environment with high glucose content and low pH. Current sterile dialysis solutions cause inflammation in the submesothelial compact zone, leading to fibrosis, angiogenesis, and, eventually, ultrafiltration failure. Although the normal interstitium separates the peritoneal microvasculature from the dialysis fluid and makes transperitoneal transport less efficient, changes in the submesothelial compact zone can result in progressive increases in solute transfer and ultrafiltration diminution. Th

APA, Harvard, Vancouver, ISO, and other styles

23

Abboud, Hanna E. "Cytokine mediators of renal inflammation." Current Opinion in Nephrology and Hypertension 3, no. 3 (1994): 329–33. http://dx.doi.org/10.1097/00041552-199405000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Schirripa, Maria Laura, Maria Pia Scarpelli, and Cristian Palmiere. "Mediators of Inflammation in Asthma." American Journal of Forensic Medicine and Pathology 38, no. 2 (2017): 153–58. http://dx.doi.org/10.1097/paf.0000000000000306.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Steinhubl, Steven R. "Platelets as Mediators of Inflammation." Hematology/Oncology Clinics of North America 21, no. 1 (2007): 115–21. http://dx.doi.org/10.1016/j.hoc.2006.11.015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Hoch, Matti, Jannik Rauthe, Konstantin Cesnulevicius, et al. "Cell-Type-Specific Gene Regulatory Networks of Pro-Inflammatory and Pro-Resolving Lipid Mediator Biosynthesis in the Immune System." International Journal of Molecular Sciences 24, no. 5 (2023): 4342. http://dx.doi.org/10.3390/ijms24054342.

Full text

Abstract:

Lipid mediators are important regulators in inflammatory responses, and their biosynthetic pathways are targeted by commonly used anti-inflammatory drugs. Switching from pro-inflammatory lipid mediators (PIMs) to specialized pro-resolving (SPMs) is a critical step toward acute inflammation resolution and preventing chronic inflammation. Although the biosynthetic pathways and enzymes for PIMs and SPMs have now been largely identified, the actual transcriptional profiles underlying the immune cell type-specific transcriptional profiles of these mediators are still unknown. Using the Atlas of Inf

APA, Harvard, Vancouver, ISO, and other styles

27

Ishihara, Tomoaki, Mio Yoshida, and Makoto Arita. "Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis." International Immunology 31, no. 9 (2019): 559–67. http://dx.doi.org/10.1093/intimm/dxz001.

Full text

Abstract:

AbstractOmega-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, display a wide range of beneficial effects in humans and animals. Many of the biological functions of PUFAs are mediated via bioactive metabolites produced by fatty acid oxygenases such as cyclooxygenases, lipoxygenases and cytochrome P450 monooxygenases. Liquid chromatography–tandem mass spectrometry-based mediator lipidomics revealed a series of novel bioactive lipid mediators derived from omega-3 PUFAs. Here, we describe recent advances on omega-3 PUFA-derive

APA, Harvard, Vancouver, ISO, and other styles

28

Harold Adrian, Liemena, Budi Satrijo, Djanggan Sargowo, and Indra Prasetya. "The Role of Colchicine in Acute Coronary Syndrome." Heart Science Journal 1, no. 4 (2020): 4–8. http://dx.doi.org/10.21776/ub.hsj.2020.001.04.02.

Full text

Abstract:

Background: Despite the advances of current optimal treatment of atherosclerotic disease, the incidence of events after acute coronary syndrome (ACS) remains high. Colchicine, with its well-established pleiotropic anti-inflam- matory effects, may inhibit NLRP3 inflammasome, a key mediator in atherosclerosis-associated inflammation (AAI) thus reducing systemic inflammation. NRLP3 inflammasome activation inside leukocytes (mainly monocytes and neutrophils) is precipitated by cholesterol crystals that are present in all atherosclerosis stages. 􏰟􏰋􏰡􏰈􏰇􏱎􏰋􏰇􏰆􏰂 􏰍􏰀􏰂􏰅􏰩􏰍􏰂􏰅􏰃􏰆 􏰃􏰜 􏰢􏰎􏰃􏰐􏰅􏰆􏰜􏰏􏰍􏰝􏰝􏰍􏰂􏰃􏰎􏰁 􏰀􏰁􏰂􏰃􏰄􏰅􏰆􏰇􏰈 􏰈

APA, Harvard, Vancouver, ISO, and other styles

29

Bannenberg, Gerhard, Makoto Arita, and Charles N. Serhan. "Endogenous Receptor Agonists: Resolving Inflammation." Scientific World JOURNAL 7 (2007): 1440–62. http://dx.doi.org/10.1100/tsw.2007.188.

Full text

Abstract:

Controlled resolution or the physiologic resolution of a well-orchestrated inflammatory response at the tissue level is essential to return to homeostasis. A comprehensive understanding of the cellular and molecular events that control the termination of acute inflammation is needed in molecular terms given the widely held view that aberrant inflammation underlies many common diseases. This review focuses on recent advances in the understanding of the role of arachidonic acid and ω-3 polyunsaturated fatty acids (PUFA)–derived lipid mediators in regulating the resolution of inflammation. Using

APA, Harvard, Vancouver, ISO, and other styles

30

Lam, Derek, Devon Harris, and Zhenyu Qin. "Inflammatory Mediator Profiling Reveals Immune Properties of Chemotactic Gradients and Macrophage Mediator Production Inhibition during Thioglycollate Elicited Peritoneal Inflammation." Mediators of Inflammation 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/931562.

Full text

Abstract:

Understanding of spatiotemporal profiling of inflammatory mediators and their associations with MΦ accumulation is crucial to elucidate the complex immune properties. Here, we used murine thioglycollate elicited peritonitis to determine concentrations of 23 inflammatory mediators in peritoneal exudates and plasma before (day 0) and after (days 1 and 3) thioglycollate administration to peritoneal cavities; these mediators included TNF-α, FGF-9, IFN-γ, IP-10, RANTES, IL-1α, IL-6, IL-7, IL-10, IL-11, IL-12p70, IL-17A, lymphotactin, OSM, KC/GRO, SCF, MIP-1β, MIP-2, TIMP-1, VEGF-A, MCP-1, MCP-3, an

APA, Harvard, Vancouver, ISO, and other styles

31

Shavazi, Nurali Mamedovich Tagayeva Aziza Odiljonovna. "SARS IN NEONATOLOGY." Yosh olimlar 1, no. 8 (2023): 91–93. https://doi.org/10.5281/zenodo.8050697.

Full text

Abstract:

SARS is the most common pathology in both children and adults, especially in the winter period of diseases. Inflammation of the mucosa of the upper and lower respiratory tract is accompanied by hypersecretion of viscous mucus, edema of the mucous membrane of the respiratory tract, impaired mucociliary transport and bronchial obstruction. Inflammation of the mucous membrane occurs with the participation of humoral and cellular mediators of inflammation, the main role in this case belongs to the cellular mediator - eicosanoids.

APA, Harvard, Vancouver, ISO, and other styles

32

Avenatti, R. C. "The intersection of inflammation, insulin resistance and ageing: implications for the study of molecular signalling pathways in horses." Comparative Exercise Physiology 8, no. 3-4 (2012): 153–71. http://dx.doi.org/10.3920/cep12018.

Full text

Abstract:

Inflammation-associated insulin resistance contributes to chronic disease in humans and other long-lived species, such as horses. Insulin resistance arises due to an imbalance among molecular signalling mediators in response to pro-inflammatory cytokines in the aged and obese. The mammalian heat shock protein response has received much attention as an avenue for attenuating inflammatory mediator signalling and for contributing to preservation and restoration of insulin signalling in metabolically important tissues. Data on heat shock proteins and inflammatory signalling mediators in untrained

APA, Harvard, Vancouver, ISO, and other styles

33

Kharbanda, Rajat, and Tarun Bansal. "Adipokines: mediators of immunity and inflammation." International Journal of Research in Medical Sciences 8, no. 7 (2020): 2746. http://dx.doi.org/10.18203/2320-6012.ijrms20202929.

Full text

Abstract:

White adipose tissue has emerged as a highly dynamic organ that releases a plethora of immune and inflammatory mediators that are involved in obesity, metabolic syndrome and immune mediated diseases. Adipokines have complex role in various physiological and pathological processes by exerting potent modulatory actions on target tissues In this Review, In this review, we explore the effects of different adipokines, focusing primarily on leptin, adiponectin, visfatin and resistin in causing immune-mediated and/or inflammatory diseases.

APA, Harvard, Vancouver, ISO, and other styles

34

Herkel, Johannes, and Dirk Schmidt-Arras. "Mediators of liver inflammation and carcinogenesis." Seminars in Immunopathology 43, no. 4 (2021): 477–79. http://dx.doi.org/10.1007/s00281-021-00880-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Flower, R. J. "Inflammation: The mediators of steroid action." Nature 320, no. 6057 (1986): 20. http://dx.doi.org/10.1038/320020a0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Jose, P. J. "Complement-derived peptide mediators of inflammation." British Medical Bulletin 43, no. 2 (1987): 336–49. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072186.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Lerner, Ulf H., and Goran Sundquist. "Mediators of inflammation-induced bone resorption." Dental Traumatology 7, no. 4 (1991): 186. http://dx.doi.org/10.1111/j.1600-9657.1991.tb00206.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Wallace, John L., Angela Ianaro, Kyle L. Flannigan, and Giuseppe Cirino. "Gaseous mediators in resolution of inflammation." Seminars in Immunology 27, no. 3 (2015): 227–33. http://dx.doi.org/10.1016/j.smim.2015.05.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

LUGER, T. "C057 Mediators of immunity and inflammation." Journal of the European Academy of Dermatology and Venereology 9 (September 1997): S70—S71. http://dx.doi.org/10.1016/s0926-9959(97)89132-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Leid, R. Wes, and Kathleen A. Potter. "Inflammation and Mediators of Lung Injury." Veterinary Clinics of North America: Food Animal Practice 1, no. 2 (1985): 377–400. http://dx.doi.org/10.1016/s0749-0720(15)31332-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

FORD-HUTCHINSON, A. W., and ANITA RACKMAN. "Leukotrienes as mediators of skin inflammation." British Journal of Dermatology 109 (July 29, 2006): 26–29. http://dx.doi.org/10.1111/j.1365-2133.1983.tb06814.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

BATSFORD, STEPHEN R. "Cationic antigens as mediators of inflammation." APMIS 99, no. 1-6 (1991): 1–9. http://dx.doi.org/10.1111/j.1699-0463.1991.tb05110.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Spiropoulos, Kostas, Nikolaos Siafakas, Marc Miravitlles, Francesco Blasi, and Kiriakos Karkoulias. "Mediators of Inflammation in Pulmonary Diseases." Mediators of Inflammation 2015 (2015): 1–2. http://dx.doi.org/10.1155/2015/739219.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Bacon, Kevin B., and Thomas J. Schall. "Chemokines as Mediators of Allergic Inflammation." International Archives of Allergy and Immunology 109, no. 2 (1996): 97–109. http://dx.doi.org/10.1159/000237207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Scott, Dugald T., Francis Y. Lam, and William R. Ferrell. "Acute joint inflammation—Mechanisms and mediators." General Pharmacology: The Vascular System 25, no. 7 (1994): 1285–96. http://dx.doi.org/10.1016/0306-3623(94)90151-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Lowry, Stephen F. "Cytokine Mediators of Immunity and Inflammation." Archives of Surgery 128, no. 11 (1993): 1235. http://dx.doi.org/10.1001/archsurg.1993.01420230063010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Shi, Xuan-Zheng, John H. Winston, and Sushil K. Sarna. "Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis." American Journal of Physiology-Gastrointestinal and Liver Physiology 300, no. 1 (2011): G41—G51. http://dx.doi.org/10.1152/ajpgi.00358.2010.

Full text

Abstract:

Crohn's disease and ulcerative colitis are clinically, immunologically, and morphologically distinct forms of inflammatory bowel disease (IBD). However, smooth muscle function is impaired similarly in both diseases, resulting in diarrhea. We tested the hypothesis that differential cellular, genetic, and immunological mechanisms mediate smooth muscle dysfunction in two animal models believed to represent the two diseases. We used the rat models of trinitrobenzene sulfonic acid (TNBS)- and dextran sodium sulfate (DSS)-induced colonic inflammations, which closely mimic the clinical and morphologi

APA, Harvard, Vancouver, ISO, and other styles

48

Wallace, J. L. "Lipid mediators of inflammation in gastric ulcer." American Journal of Physiology-Gastrointestinal and Liver Physiology 258, no. 1 (1990): G1—G11. http://dx.doi.org/10.1152/ajpgi.1990.258.1.g1.

Full text

Abstract:

The interest in lipid mediators of inflammation as potential contributors to the pathogenesis of gastric ulcer has increased markedly over the past 20 yr. Although a great deal is known about the actions of mediators such as leukotrienes, thromboxane, and platelet-activating factor in experimental models of ulceration, evidence supporting a role for these mediators in human gastric ulcer is sorely lacking. This review attempts to answer a number of questions regarding the contribution of these mediators to the pathogenesis of gastric ulceration and the possible use of specific inhibitors, anta

APA, Harvard, Vancouver, ISO, and other styles

49

Gushchin, Igor S. "Interactions of mast cells and eosinophils in allergic response." Russian Journal of Allergy 17, no. 2 (2020): 5–17. http://dx.doi.org/10.36691/rja1363.

Full text

Abstract:

Mast cells (MCs) and eosinophils (EOs) appeared hundreds of millions of years ago during the evolutionary process and continue to be retained by all vertebrate species. There is no convincing evidence of the absence of these cells in vertebrates under normal conditions. These cells are involved in the reactions of innate and adaptive immunity, in the control of tissue growth and tissue remodeling, activation of adipose tissue, affect reproductive functions and have a wide range of mediators involved in homeostasis. It is known that the interaction of these cells is involved in the initiation a

APA, Harvard, Vancouver, ISO, and other styles

50

Knuplez, Eva, Eva Maria Sturm, and Gunther Marsche. "Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids." International Journal of Molecular Sciences 22, no. 9 (2021): 4356. http://dx.doi.org/10.3390/ijms22094356.

Full text

Abstract:

Eosinophils are important effector cells involved in allergic inflammation. When stimulated, eosinophils release a variety of mediators initiating, propagating, and maintaining local inflammation. Both, the activity and concentration of secreted and cytosolic phospholipases (PLAs) are increased in allergic inflammation, promoting the cleavage of phospholipids and thus the production of reactive lipid mediators. Eosinophils express high levels of secreted phospholipase A2 compared to other leukocytes, indicating their direct involvement in the production of lipid mediators during allergic infla

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!